Healthcare provider profile · identity verified

Don A Dearmitt, MD

Family Practice · HARRISBURG, PA · NPI 1932160306

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	594	193
Lisinopril	Lisinopril	369	114
Amlodipine Besylate	Amlodipine Besylate	321	117
Escitalopram Oxalate	Escitalopram Oxalate	235	75
Metformin Hcl Er	Metformin Hcl	225	69
Losartan Potassium	Losartan Potassium	210	73
Levothyroxine Sodium	Levothyroxine Sodium	180	58
Metoprolol Succinate	Metoprolol Succinate	174	59
Simvastatin	Simvastatin	164	52
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	148	148
Tamsulosin Hcl	Tamsulosin Hcl	138	47
Hydrochlorothiazide	Hydrochlorothiazide	135	46
Pantoprazole Sodium	Pantoprazole Sodium	131	42
Omeprazole	Omeprazole	130	40
Rosuvastatin Calcium	Rosuvastatin Calcium	120	37
Allopurinol	Allopurinol	115	42
Lorazepam	Lorazepam	110	32
Ozempic	Semaglutide	108	19
Gabapentin	Gabapentin	107	33
Albuterol Sulfate Hfa	Albuterol Sulfate	97	31
Repaglinide	Repaglinide	91	34
Pravastatin Sodium	Pravastatin Sodium	90	28
Clopidogrel	Clopidogrel Bisulfate	88	19
Glimepiride	Glimepiride	87	19
Bupropion Xl	Bupropion Hcl	83	30
Pioglitazone Hcl	Pioglitazone Hcl	82	29
Fenofibrate	Fenofibrate	80	20
Finasteride	Finasteride	80	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	23
Metformin Hcl	Metformin Hcl	75	24
Alprazolam	Alprazolam	73	16
Furosemide	Furosemide	73	27
Chlorthalidone	Chlorthalidone	67	23
Eliquis	Apixaban	67	18
Fluticasone Propionate	Fluticasone Propionate	64	23
Carvedilol	Carvedilol	60	15
Valsartan	Valsartan	57	20
Tramadol Hcl	Tramadol Hcl	56	20
Sertraline Hcl	Sertraline Hcl	53	17
Montelukast Sodium	Montelukast Sodium	51	11
Alendronate Sodium	Alendronate Sodium	50	15
Januvia	Sitagliptin Phosphate	49	suppressed
Potassium Chloride	Potassium Chloride	49	17
Meloxicam	Meloxicam	48	14
Citalopram Hbr	Citalopram Hydrobromide	47	13
Duloxetine Hcl	Duloxetine Hcl	47	14
Clonazepam	Clonazepam	46	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	46	17
Trazodone Hcl	Trazodone Hcl	45	12
Atenolol	Atenolol	41	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	39	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	38	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	suppressed
Donepezil Hcl	Donepezil Hcl	37	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	12
Warfarin Sodium	Warfarin Sodium	37	suppressed
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	13
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	24
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Mounjaro	Tirzepatide	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Jardiance	Empagliflozin	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Mometasone Furoate	Mometasone Furoate	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Tradjenta	Linagliptin	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Famotidine	Famotidine	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	20	18
Bumetanide	Bumetanide	19	suppressed
Diazepam	Diazepam	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	15
Risperidone	Risperidone	19	suppressed
Prednisone	Prednisone	18	13
Spironolactone	Spironolactone	18	suppressed
Jantoven	Warfarin Sodium	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Ramipril	Ramipril	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Anastrozole	Anastrozole	15	suppressed
Clonidine	Clonidine	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Dutasteride	Dutasteride	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Modafinil	Modafinil	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Azithromycin	Azithromycin	12	12
Clonidine Hcl	Clonidine Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Quinine Sulfate	Quinine Sulfate	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Xeljanz	Tofacitinib Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error